Test models included

Genomic

Methods with commercial potential

Assay for drug-induced liver cholestasis by flow cytometry

Multiparametric assay for druginduced steatosis

Nephrotoxicity

Endpoints

Choleostasis

Steatosis

Perfusion culture

Expected field of application

Pharmaceuticals: drug

development, toxicity

Stage of development

In-house optimized

Expected regulatory acceptance

Expected interest from the market

A producers would be convenient

for marketing